Portfolio Holdings Detail for ISIN IE00BDZVHG35
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) |
| Issuer | Blackrock |
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
| ETF Ticker | BTEE(USD) LSE |
| ETF Ticker | BTEE.L(GBP) LSE |
Holdings detail for INVA
| Stock Name | Innoviva Inc |
| Ticker | INVA(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US45781M1018 |
| LEI | 549300ACOX4QTBES6535 |
Show aggregate INVA holdings
News associated with INVA
- Innoviva (NASDAQ:INVA) Stock Rating Upgraded by Wall Street Zen
- Wall Street Zen upgraded shares of Innoviva (NASDAQ:INVA – Free Report) from a buy rating to a strong-buy rating in a report released on Monday morning. Several other analysts also recently weighed in on INVA. Cantor Fitzgerald began coverage on Innoviva in a research report on Friday, July 11th. They issued an “overweight” rating and […] - 2025-09-02 03:06:54
- Comparing Innoviva (NASDAQ:INVA) and Novo Nordisk A/S (NYSE:NVO)
- Innoviva (NASDAQ:INVA – Get Free Report) and Novo Nordisk A/S (NYSE:NVO – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings. Institutional & Insider Ownership 99.1% of Innoviva shares […] - 2025-09-01 03:01:00
- Deutsche Bank AG Trims Stock Position in Innoviva, Inc. (NASDAQ:INVA)
- Deutsche Bank AG decreased its position in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) by 4.2% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 827,730 shares of the biotechnology company’s stock after selling 36,549 shares during the quarter. Deutsche Bank AG owned approximately […] - 2025-08-15 05:51:00
- Innoviva (NASDAQ:INVA) and AbbVie (NYSE:ABBV) Financial Comparison
- Innoviva (NASDAQ:INVA – Get Free Report) and AbbVie (NYSE:ABBV – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Profitability This table compares Innoviva and AbbVie’s net margins, return […] - 2025-08-13 04:40:48
- Innoviva (NASDAQ:INVA) Stock Price Up 8.2% on Analyst Upgrade
- Innoviva, Inc. (NASDAQ:INVA – Get Free Report) shares were up 8.2% on Monday after HC Wainwright raised their price target on the stock from $40.00 to $45.00. HC Wainwright currently has a buy rating on the stock. Innoviva traded as high as $19.66 and last traded at $19.84. Approximately 205,104 shares traded hands during trading, […] - 2025-08-13 02:55:07
- Innoviva (NASDAQ:INVA) and AbbVie (NYSE:ABBV) Head-To-Head Review
- Innoviva (NASDAQ:INVA – Get Free Report) and AbbVie (NYSE:ABBV – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Earnings & Valuation This table compares Innoviva and AbbVie”s gross […] - 2025-08-06 04:40:51
- Principal Financial Group Inc. Grows Stock Position in Innoviva, Inc. (NASDAQ:INVA)
- Principal Financial Group Inc. boosted its stake in Innoviva, Inc. (NASDAQ:INVA – Free Report) by 2.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 305,476 shares of the biotechnology company’s stock after acquiring an additional 7,700 shares during the quarter. […] - 2025-07-17 05:51:13
- Innoviva (NASDAQ:INVA) vs. Merck & Co., Inc. (NYSE:MRK) Head to Head Comparison
- Innoviva (NASDAQ:INVA – Get Free Report) and Merck & Co., Inc. (NYSE:MRK – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Earnings & Valuation This table compares Innoviva […] - 2025-07-17 04:38:50
- New York State Teachers Retirement System Has $1.04 Million Holdings in Innoviva, Inc. (NASDAQ:INVA)
- New York State Teachers Retirement System lessened its holdings in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) by 5.7% during the first quarter, Holdings Channel.com reports. The institutional investor owned 57,498 shares of the biotechnology company’s stock after selling 3,448 shares during the quarter. New York State Teachers Retirement System’s holdings in Innoviva were […] - 2025-07-10 04:59:01
- Illinois Municipal Retirement Fund Reduces Stock Position in Innoviva, Inc. (NASDAQ:INVA)
- Illinois Municipal Retirement Fund lowered its stake in Innoviva, Inc. (NASDAQ:INVA – Free Report) by 4.3% during the 1st quarter, HoldingsChannel reports. The firm owned 27,806 shares of the biotechnology company’s stock after selling 1,260 shares during the period. Illinois Municipal Retirement Fund’s holdings in Innoviva were worth $504,000 as of its most recent filing […] - 2025-07-04 04:46:49
- Exchange Traded Concepts LLC Grows Stock Holdings in Innoviva, Inc. (NASDAQ:INVA)
- Exchange Traded Concepts LLC grew its holdings in Innoviva, Inc. (NASDAQ:INVA – Free Report) by 8.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 176,025 shares of the biotechnology company’s stock after purchasing an additional 14,020 shares during the quarter. Exchange […] - 2025-06-17 06:15:01
- FDA Grants Priority Review For Innoviva's Zoliflodacin For Treatment Of Uncomplicated Gonorrhea
- (RTTNews) - Innoviva Specialty Therapeutics, Inc., a unit of Innoviva, Inc. (INVA), in partnership with the Global Antibiotic Research & Development Partnership (GARDP), Thursday said that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the New Drug Ap - 2025-06-12 08:48:08
- MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 1,162 Shares of Innoviva, Inc. (NASDAQ:INVA)
- MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) by 3.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 31,490 shares of the biotechnology company’s stock after acquiring an additional 1,162 shares […] - 2025-05-29 05:40:50
- Two Sigma Investments LP Has $4.56 Million Stock Position in Innoviva, Inc. (NASDAQ:INVA)
- Two Sigma Investments LP reduced its position in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) by 45.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 262,739 shares of the biotechnology company’s stock after selling 221,073 shares […] - 2025-05-28 05:20:52
- 10,612 Shares in Innoviva, Inc. (NASDAQ:INVA) Purchased by Cubist Systematic Strategies LLC
- Cubist Systematic Strategies LLC purchased a new position in Innoviva, Inc. (NASDAQ:INVA – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 10,612 shares of the biotechnology company’s stock, valued at approximately $184,000. Other hedge funds and other institutional investors also […] - 2025-05-19 04:38:50
- Sum Up The Parts: IJR Could Be Worth $128
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-15 07:40:06
- MetLife Investment Management LLC Acquires 1,731 Shares of Innoviva, Inc. (NASDAQ:INVA)
- MetLife Investment Management LLC raised its holdings in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) by 5.2% in the 4th quarter, Holdings Channel reports. The firm owned 34,961 shares of the biotechnology company’s stock after purchasing an additional 1,731 shares during the quarter. MetLife Investment Management LLC’s holdings in Innoviva were worth $607,000 at […] - 2025-05-05 05:30:51
- Innoviva (NASDAQ:INVA) Upgraded by StockNews.com to “Buy” Rating
- Innoviva (NASDAQ:INVA – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday. Separately, Scotiabank started coverage on shares of Innoviva in a report on Friday, March 7th. They issued a “sector outperform” rating and a $55.00 […] - 2025-05-02 02:46:47
- Dimensional Fund Advisors LP Grows Position in Innoviva, Inc. (NASDAQ:INVA)
- Dimensional Fund Advisors LP raised its position in Innoviva, Inc. (NASDAQ:INVA – Free Report) by 4.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,919,518 shares of the biotechnology company’s stock after buying an additional 226,592 shares during the […] - 2025-04-30 06:00:57
- Look Under The Hood: IJR Has 39% Upside
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-14 09:05:39
- Innoviva (NASDAQ:INVA) Downgraded to “Hold” Rating by StockNews.com
- Innoviva (NASDAQ:INVA – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Tuesday. Separately, Scotiabank started coverage on shares of Innoviva in a research report on Friday, March 7th. They set a “sector outperform” rating and a $55.00 target price […] - 2025-04-03 02:27:03
- 72,400 Shares in Innoviva, Inc. (NASDAQ:INVA) Acquired by KLP Kapitalforvaltning AS
- KLP Kapitalforvaltning AS acquired a new stake in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 72,400 shares of the biotechnology company’s stock, valued at approximately $1,256,000. KLP Kapitalforvaltning AS owned 0.12% of Innoviva as […] - 2025-03-30 06:16:54
- Innoviva (NASDAQ:INVA) Upgraded by StockNews.com to “Buy” Rating
- StockNews.com upgraded shares of Innoviva (NASDAQ:INVA – Free Report) from a hold rating to a buy rating in a research note published on Monday morning. Separately, Scotiabank began coverage on Innoviva in a research report on Friday, March 7th. They issued a “sector outperform” rating and a $55.00 target price on the stock. Read Our […] - 2025-03-25 04:09:01
- Innoviva (NASDAQ:INVA) Upgraded at StockNews.com
- StockNews.com upgraded shares of Innoviva (NASDAQ:INVA – Free Report) from a hold rating to a buy rating in a report released on Friday. Separately, Scotiabank started coverage on Innoviva in a research report on Friday. They set a “sector outperform” rating and a $55.00 price objective on the stock. Check Out Our Latest Analysis on […] - 2025-03-10 04:28:55
- Scotiabank Begins Coverage on Innoviva (NASDAQ:INVA)
- Scotiabank began coverage on shares of Innoviva (NASDAQ:INVA – Free Report) in a research report released on Friday morning, MarketBeat Ratings reports. The brokerage issued a sector outperform rating and a $55.00 target price on the biotechnology company’s stock. Separately, StockNews.com cut Innoviva from a “buy” rating to a “hold” rating in a research report […] - 2025-03-10 04:28:54
- Illinois Municipal Retirement Fund Increases Holdings in Innoviva, Inc. (NASDAQ:INVA)
- Illinois Municipal Retirement Fund increased its stake in Innoviva, Inc. (NASDAQ:INVA – Free Report) by 2.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,066 shares of the biotechnology company’s stock after acquiring an additional 784 shares during […] - 2025-03-05 08:41:50
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) INVA holdings
| Date | Number of INVA Shares Held | Base Market Value of INVA Shares | Local Market Value of INVA Shares | Change in INVA Shares Held | Change in INVA Base Value | Current Price per INVA Share Held | Previous Price per INVA Share Held |
|---|
| 2025-12-03 (Wednesday) | 43,559 | USD 908,641 | USD 908,641 | 0 | USD -5,227 | USD 20.86 | USD 20.98 |
| 2025-12-02 (Tuesday) | 43,559 | USD 913,868 | USD 913,868 | 1,560 | USD 25,169 | USD 20.98 | USD 21.16 |
| 2025-12-01 (Monday) | 41,999 | USD 888,699 | USD 888,699 | 0 | USD -23,939 | USD 21.16 | USD 21.73 |
| 2025-11-28 (Friday) | 41,999 | USD 912,638 | USD 912,638 | 104 | USD 3,098 | USD 21.73 | USD 21.71 |
| 2025-11-27 (Thursday) | 41,895 | USD 909,540 | USD 909,540 | 0 | USD 0 | USD 21.71 | USD 21.71 |
| 2025-11-26 (Wednesday) | 41,895 | USD 909,540 | USD 909,540 | 312 | USD 6,357 | USD 21.71 | USD 21.72 |
| 2025-11-25 (Tuesday) | 41,583 | USD 903,183 | USD 903,183 | 520 | USD 28,952 | USD 21.72 | USD 21.29 |
| 2025-11-24 (Monday) | 41,063 | USD 874,231 | USD 874,231 | 104 | USD 15,730 | USD 21.29 | USD 20.96 |
| 2025-11-21 (Friday) | 40,959 | USD 858,501 | USD 858,501 | 0 | USD -8,191 | USD 20.96 | USD 21.16 |
| 2025-11-20 (Thursday) | 40,959 | USD 866,692 | USD 866,692 | -416 | USD -13,354 | USD 21.16 | USD 21.27 |
| 2025-11-19 (Wednesday) | 41,375 | USD 880,046 | USD 880,046 | 104 | USD -22,551 | USD 21.27 | USD 21.87 |
| 2025-11-18 (Tuesday) | 41,271 | USD 902,597 | USD 902,597 | 624 | USD 9,582 | USD 21.87 | USD 21.97 |
| 2025-11-17 (Monday) | 40,647 | USD 893,015 | USD 893,015 | 208 | USD -6,753 | USD 21.97 | USD 22.25 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of INVA by Blackrock for IE00BDZVHG35
Show aggregate share trades of INVA| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-12-02 | BUY | 1,560 | 21.310 | 20.640 | 20.707 | USD 32,303 | 19.02 |
| 2025-11-28 | BUY | 104 | 21.785 | 21.380 | 21.420 | USD 2,228 | 19.00 |
| 2025-11-26 | BUY | 312 | 22.160 | 21.669 | 21.718 | USD 6,776 | 18.97 |
| 2025-11-26 | BUY | 312 | 22.160 | 21.669 | 21.718 | USD 6,776 | 18.97 |
| 2025-11-25 | BUY | 520 | 21.840 | 21.200 | 21.264 | USD 11,057 | 18.96 |
| 2025-11-24 | BUY | 104 | 21.490 | 20.960 | 21.013 | USD 2,185 | 18.95 |
| 2025-11-20 | SELL | -416 | 21.600 | 21.080 | 21.132 | USD -8,791 | 18.92 Loss of -919 on sale |
| 2025-11-19 | BUY | 104 | 22.480 | 21.205 | 21.332 | USD 2,219 | 18.91 |
| 2025-11-18 | BUY | 624 | 22.280 | 21.730 | 21.785 | USD 13,594 | 18.90 |
| 2025-11-17 | BUY | 208 | 22.510 | 21.960 | 22.015 | USD 4,579 | 18.88 |
| 2025-11-14 | BUY | 104 | 22.345 | 21.810 | 21.863 | USD 2,274 | 18.86 |
| 2025-11-12 | BUY | 104 | 22.455 | 21.690 | 21.767 | USD 2,264 | 18.83 |
| 2025-11-10 | BUY | 103 | 20.920 | 20.255 | 20.321 | USD 2,093 | 18.80 |
| 2025-11-06 | BUY | 103 | 20.900 | 18.850 | 19.055 | USD 1,963 | 18.78 |
| 2025-11-04 | BUY | 104 | 18.300 | 17.910 | 17.949 | USD 1,867 | 18.78 |
| 2025-10-30 | BUY | 520 | 17.950 | 17.530 | 17.572 | USD 9,137 | 18.80 |
| 2025-10-29 | BUY | 208 | 17.570 | 17.800 | 17.777 | USD 3,698 | 18.80 |
| 2025-10-22 | SELL | -412 | 18.350 | 18.790 | 18.746 | USD -7,723 | 18.83 Profit of 34 on sale |
| 2025-10-20 | BUY | 206 | 17.210 | 17.330 | 17.318 | USD 3,568 | 18.85 |
| 2025-10-17 | BUY | 515 | 17.270 | 17.500 | 17.477 | USD 9,001 | 18.85 |
| 2025-10-15 | BUY | 824 | 17.390 | 17.480 | 17.471 | USD 14,396 | 18.86 |
| 2025-10-03 | BUY | 728 | 17.480 | 17.790 | 17.759 | USD 12,929 | 18.88 |
| 2025-10-02 | BUY | 104 | 17.660 | 18.090 | 18.047 | USD 1,877 | 18.89 |
| 2025-09-30 | BUY | 208 | 18.250 | 18.580 | 18.547 | USD 3,858 | 18.90 |
| 2025-09-26 | BUY | 208 | 18.860 | 18.880 | 18.878 | USD 3,927 | 18.90 |
| 2025-09-25 | BUY | 208 | 18.570 | 19.370 | 19.290 | USD 4,012 | 18.90 |
| 2025-09-18 | BUY | 109 | 19.890 | 19.900 | 19.899 | USD 2,169 | 18.90 |
| 2025-09-17 | BUY | 327 | 19.380 | 19.660 | 19.632 | USD 6,420 | 18.89 |
| 2025-07-17 | SELL | -216 | 19.880 | 20.580 | 20.510 | USD -4,430 | 18.88 Loss of -353 on sale |
| 2025-07-11 | SELL | -864 | 18.770 | 19.400 | 19.337 | USD -16,707 | 18.86 Loss of -416 on sale |
| 2025-07-02 | BUY | 5,940 | 19.400 | 19.870 | 19.823 | USD 117,749 | 18.85 |
| 2025-06-25 | BUY | 216 | 20.480 | 20.840 | 20.804 | USD 4,494 | 18.81 |
| 2025-06-20 | BUY | 1,436 | 21.000 | 21.590 | 21.531 | USD 30,919 | 18.76 |
| 2025-06-11 | BUY | 206 | 21.370 | 21.730 | 21.694 | USD 4,469 | 18.62 |
| 2025-06-10 | BUY | 206 | 21.530 | 21.980 | 21.935 | USD 4,519 | 18.60 |
| 2025-06-04 | SELL | -104 | 20.880 | 20.960 | 20.952 | USD -2,179 | 18.51 Loss of -254 on sale |
| 2025-04-23 | BUY | 103 | 18.370 | 18.620 | 18.595 | USD 1,915 | 18.42 |
| 2025-04-10 | SELL | -824 | 17.100 | 17.260 | 17.244 | USD -14,209 | 18.46 Profit of 1,004 on sale |
| 2025-04-08 | SELL | -103 | 17.250 | 17.890 | 17.826 | USD -1,836 | 18.49 Profit of 68 on sale |
| 2025-04-07 | SELL | -103 | 17.510 | 17.840 | 17.807 | USD -1,834 | 18.50 Profit of 71 on sale |
| 2025-04-04 | SELL | -520 | 17.720 | 18.030 | 17.999 | USD -9,359 | 18.51 Profit of 266 on sale |
| 2025-04-01 | BUY | 428 | 17.940 | 18.140 | 18.120 | USD 7,755 | 18.52 |
| 2025-03-31 | SELL | -312 | 18.130 | 18.270 | 18.256 | USD -5,696 | 18.53 Profit of 84 on sale |
| 2025-03-21 | BUY | 1,399 | 17.270 | 17.400 | 17.387 | USD 24,324 | 18.60 |
| 2025-03-14 | SELL | -1,600 | 17.390 | 17.520 | 17.507 | USD -28,011 | 18.69 Profit of 1,893 on sale |
| 2025-03-07 | SELL | -200 | 17.640 | 17.850 | 17.829 | USD -3,566 | 18.78 Profit of 190 on sale |
| 2025-03-04 | SELL | -100 | 17.570 | 18.190 | 18.128 | USD -1,813 | 18.84 Profit of 71 on sale |
| 2025-02-25 | BUY | 200 | 18.030 | 18.260 | 18.237 | USD 3,647 | 18.92 |
| 2025-02-19 | SELL | -99 | 18.030 | 18.200 | 18.183 | USD -1,800 | 18.99 Profit of 80 on sale |
| 2025-02-13 | BUY | 297 | 18.220 | 18.330 | 18.319 | USD 5,441 | 19.06 |
| 2025-02-12 | BUY | 99 | 17.980 | 18.050 | 18.043 | USD 1,786 | 19.08 |
| 2025-02-11 | BUY | 396 | 18.060 | 18.080 | 18.078 | USD 7,159 | 19.10 |
| 2024-12-30 | SELL | -3,928 | 17.380 | 17.530 | 17.515 | USD -68,799 | 19.42 Profit of 7,465 on sale |
| 2024-11-18 | SELL | -1,638 | 18.950 | 19.190 | 19.166 | USD -31,394 | 19.80 Profit of 1,035 on sale |
| 2024-11-08 | SELL | -109 | 20.180 | 20.320 | 20.306 | USD -2,213 | 19.73 Loss of -62 on sale |
| 2024-10-21 | SELL | -110 | 19.850 | 20.020 | 20.003 | USD -2,200 | 0.00 Loss of -2,200 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of INVA
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 65,930 | 0 | 149,254 | 44.2% |
| 2025-09-18 | 54,680 | 0 | 119,648 | 45.7% |
| 2025-09-17 | 40,834 | 0 | 95,181 | 42.9% |
| 2025-09-16 | 227,908 | 28,600 | 465,820 | 48.9% |
| 2025-09-15 | 85,010 | 0 | 176,819 | 48.1% |
| 2025-09-12 | 156,615 | 104,900 | 229,858 | 68.1% |
| 2025-09-11 | 146,754 | 0 | 312,186 | 47.0% |
| 2025-09-10 | 75,303 | 0 | 156,342 | 48.2% |
| 2025-09-09 | 94,428 | 5,671 | 191,257 | 49.4% |
| 2025-09-08 | 77,521 | 0 | 154,072 | 50.3% |
| 2025-09-05 | 88,670 | 0 | 245,183 | 36.2% |
| 2025-09-04 | 86,526 | 0 | 170,267 | 50.8% |
| 2025-09-03 | 48,464 | 194 | 153,630 | 31.5% |
| 2025-09-02 | 119,972 | 0 | 249,504 | 48.1% |
| 2025-08-29 | 91,265 | 0 | 190,465 | 47.9% |
| 2025-08-28 | 48,895 | 0 | 140,299 | 34.9% |
| 2025-08-27 | 107,253 | 32,800 | 194,107 | 55.3% |
| 2025-08-26 | 23,532 | 0 | 145,160 | 16.2% |
| 2025-08-25 | 51,167 | 0 | 168,306 | 30.4% |
| 2025-08-22 | 35,425 | 0 | 126,656 | 28.0% |
| 2025-08-21 | 25,225 | 200 | 118,578 | 21.3% |
| 2025-08-20 | 23,281 | 590 | 143,018 | 16.3% |
| 2025-08-19 | 16,731 | 0 | 109,949 | 15.2% |
| 2025-08-18 | 190,992 | 0 | 438,041 | 43.6% |
| 2025-08-15 | 62,276 | 0 | 302,389 | 20.6% |
| 2025-08-14 | 56,515 | 0 | 301,294 | 18.8% |
| 2025-08-13 | 126,567 | 39 | 384,530 | 32.9% |
| 2025-08-12 | 221,544 | 187 | 351,909 | 63.0% |
| 2025-08-11 | 368,099 | 0 | 589,100 | 62.5% |
| 2025-08-08 | 108,860 | 0 | 228,597 | 47.6% |
| 2025-08-07 | 220,464 | 600 | 484,319 | 45.5% |
| 2025-08-06 | 65,725 | 2 | 279,150 | 23.5% |
| 2025-08-05 | 42,131 | 0 | 166,651 | 25.3% |
| 2025-08-04 | 51,724 | 14 | 196,347 | 26.3% |
| 2025-08-01 | 150,400 | 0 | 358,924 | 41.9% |
| 2025-07-31 | 48,482 | 0 | 193,499 | 25.1% |
| 2025-07-30 | 27,118 | 0 | 151,617 | 17.9% |
| 2025-07-29 | 29,865 | 0 | 121,240 | 24.6% |
| 2025-07-28 | 121,974 | 0 | 302,769 | 40.3% |
| 2025-07-25 | 130,850 | 0 | 367,274 | 35.6% |
| 2025-07-24 | 30,190 | 1 | 218,543 | 13.8% |
| 2025-07-23 | 43,352 | 0 | 213,256 | 20.3% |
| 2025-07-22 | 22,737 | 789 | 211,775 | 10.7% |
| 2025-07-21 | 34,627 | 0 | 151,496 | 22.9% |
| 2025-07-18 | 42,859 | 0 | 211,821 | 20.2% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy